SGX Pharmaceuticals, Inc.赞助的临床试验
总计5026个结果
-
National Institute of Allergy and Infectious Diseases...Genentech, Inc.; Novartis Pharmaceuticals; Rho Federal Systems Division, Inc.主动,不招人
-
OHSU Knight Cancer InstituteOregon Health and Science University; Progenics Pharmaceuticals, Inc.尚未招聘
-
Peking Union Medical College HospitalMerck Sharp & Dohme LLC; BeyondSpring Pharmaceuticals Inc.招聘中
-
Italian Network for Tumor Biotherapy FoundationBristol-Myers Squibb; Astex Pharmaceuticals, Inc.尚未招聘
-
University of MiamiWyeth-Ayesrst Pharmaceuticals, Roche Laboratories, and Fujusawa Healthcare, Inc.完全的
-
Washington University School of MedicineMillennium Pharmaceuticals, Inc.; Multiple Myeloma Research Consortium主动,不招人
-
OHSU Knight Cancer InstituteOregon Health and Science University; AMAG Pharmaceuticals, Inc.撤销
-
University of Alabama at BirminghamBayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma完全的
-
Hamid SayarBayer; Merck Sharp & Dohme LLC; Millennium Pharmaceuticals, Inc.完全的
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Astex Pharmaceuticals, Inc.完全的
-
Centre of Experimental MedicineMillennium Pharmaceuticals, Inc.终止
-
University of Alabama at BirminghamBayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma终止
-
Alison WalkerNovartis; Millennium Pharmaceuticals, Inc.完全的急性髓性白血病 | 复发性成人急性髓性白血病 | 伴有 11q23 (MLL) 异常的成人急性髓性白血病 | 伴有 Del(5q) 的成人急性髓性白血病 | 成人急性髓性白血病伴 Inv(16)(p13;q22) | 成人急性髓性白血病伴 t(16;16)(p13;q22) | 成人急性髓性白血病伴 t(8;21)(q22;q22) | 继发性急性髓性白血病 | 骨髓增生异常综合症 | 成人急性髓性白血病伴 t(15;17)(q22;q12) | 急性髓系白血病伴多系发育异常美国
-
Stanford UniversityMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.完全的
-
University of Alabama at BirminghamNational Cancer Institute (NCI); Ionis Pharmaceuticals, Inc.完全的
-
Vanderbilt University Medical CenterTeva Branded Pharmaceutical Products R&D, Inc.招聘中
-
Nanogen Pharmaceutical Biotechnology Joint Stock...Vietstar Biomedical Research; MedProve Inc完全的
-
Nanogen Pharmaceutical Biotechnology Joint Stock...Vietstar Biomedical Research; MedProve Inc完全的
-
Teva Branded Pharmaceutical Products R&D, Inc.National Cancer Institute (NCI)终止多形性胶质母细胞瘤 | 间变性星形细胞瘤 | 间变性少突胶质细胞瘤 | 间变性混合性少突星形细胞瘤
-
Teva Branded Pharmaceutical Products R&D, Inc.Cetero Research, San Antonio完全的
-
University of California, San FranciscoBayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma尚未招聘
-
Laminar PharmaceuticalsDana-Farber Cancer Institute; Hackensack Meridian Health; Laminar Pharma Inc招聘中
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLC; Xynomic Pharmaceuticals, Inc.主动,不招人
-
Carsten Bindslev-JensenNovartis Pharmaceuticals; Thermo Fisher Scientific, Inc完全的
-
European Organisation for Research and Treatment...Tragara Pharmaceuticals, Inc.完全的
-
Spectrum Pharmaceuticals, IncNational Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center完全的
-
University of California, DavisNational Cancer Institute (NCI); Genentech, Inc.; Aventis Pharmaceuticals完全的
-
Fondazione MichelangeloFondazione IRCCS Istituto Nazionale dei Tumori, Milano; Millennium Pharmaceuticals, Inc.完全的
-
Mayo ClinicNational Heart, Lung, and Blood Institute (NHLBI); Aires Pharmaceuticals, Inc.完全的
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Millennium Pharmaceuticals, Inc.完全的
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI); GlaxoSmithKline; Millennium Pharmaceuticals, Inc.终止复发性成人弥漫性大细胞淋巴瘤 | 复发性 1 级滤泡性淋巴瘤 | 复发性 2 级滤泡性淋巴瘤 | 复发性 3 级滤泡性淋巴瘤 | 复发性套细胞淋巴瘤美国
-
Genzyme, a Sanofi CompanyBayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma完全的B 细胞慢性淋巴细胞白血病 (B-CLL)英国, 比利时, 法国, 美国, 捷克共和国, 塞尔维亚
-
Stanford UniversityMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.完全的
-
Guang'anmen Hospital of China Academy of Chinese...Tasly Pharmaceuticals, Inc.完全的
-
Santalis Pharmaceuticals, Inc.Derm Research, PLLC; ClinDatrix, Inc.; Clinical Trials of Texas, Inc.; Progressive Clinical Research 和其他合作者完全的
-
SFJ Pharmaceuticals X, LTD.Merck KGaA, Darmstadt, Germany; AIO-Studien-gGmbH; Academic and Community Cancer Research United; SFJ Pharmaceuticals, Inc...撤销
-
The Third Xiangya Hospital of Central South UniversityLivzon Pharmaceutical Group Inc.; Yung Shin Pharm. Ind. Co., Ltd.完全的
-
Martha SajatovicOtsuka Pharmaceutical Development & Commercialization, Inc.完全的
-
Otsuka Pharmaceutical Development & Commercialization...H. Lundbeck A/S; PRA Health Sciences完全的
-
Seung-Jung ParkOtsuka Pharmaceutical Development & Commercialization, Inc.终止
-
Teva Branded Pharmaceutical Products R&D, Inc.United States Department of Defense撤销
-
Teva Branded Pharmaceutical Products R&D, Inc.Clalit Health Services; Rosetta Genomics完全的
-
Johnson & Johnson Pharmaceutical Research & Development...PriCara, Unit of Ortho-McNeil, Inc.完全的偏头痛 | 头痛 | 头疼
-
Johnson & Johnson Pharmaceutical Research & Development...PriCara, Unit of Ortho-McNeil, Inc.完全的
-
Johnson & Johnson Pharmaceutical Research & Development...PriCara, Unit of Ortho-McNeil, Inc.完全的
-
Johnson & Johnson Pharmaceutical Research & Development...PriCara, Unit of Ortho-McNeil, Inc.完全的
-
Johnson & Johnson Pharmaceutical Research & Development...PriCara, Unit of Ortho-McNeil, Inc.完全的尿路感染 | 肾盂肾炎
-
Johnson & Johnson Pharmaceutical Research & Development...PriCara, Unit of Ortho-McNeil, Inc.完全的
-
Johnson & Johnson Pharmaceutical Research & Development...PriCara, Unit of Ortho-McNeil, Inc.完全的